| Product |
Cas No. |
| Lacosamide |
175481-36-4 |
| Lamivudine |
134678-17-4 |
| Lamotrigine |
84057-84-1 |
| Lansoprazole |
103577-45-3 |
| Lapatinib
ditosylate |
388082-78-8 |
| Leflunomide |
75706-12-6 |
| Lenalidomide |
191732-72-6 |
| Letrozole |
112809-51-5 |
| Levetiracetam |
102767-28-2 |
| Levobupivicaine HCl |
27262-47-1 |
| Levocetirizine 2HCl |
130018-87-0 |
| Levofloxacin
hemihydrate |
138199-71-0 |
| Levofloxacin
hydrochloride |
177325-13-2 |
| Levothyroxine
sodium monohydrate |
25416-65-3 |
| Lisinopril |
83915-83-7 |
| Lisuride maleate |
19875-60-6 |
| Lopinavir |
192725-17-0 |
| Loratidine |
79794-75-5 |
| Lorcaserin
hydrochloride |
846589-98-8 |
| Lornoxicam |
70374-39-9 |
| Losartan potassium |
124750-99-8 |
| Losartan acid |
124750-92-1 |
| Lovastatin |
75330-75-5 |
| Loxapine succinate |
27833-64-3 |
| Loxoprofen sodium |
80382-23-6 |
| Lumefantrine |
82186-77-4 |
| Lumiracoxib |
220991-20-8 |
| Back
to
Top |
|
|
Kemprotec
can provide laboratory quantities of a
wide range of materials for R & D usage. These are sourced from
a
small number of carefully selected producers in China, Europe, India
and the USA. All products are manufactured by Companies committed to
today's most rigorous global norms in their Quality Management
practices, environment and hygiene-oriented methods, and safety
standards.
The list includes items in stock or
supplied within the last twelve months but is not exhaustive and we
would be happy to quote for items not shown. For more information or to
discuss your needs contact sales:
Patented products
available for R&D use as permitted under
35 USC 271 (e) (1)
Copyright
©
Kemprotec Limited 1998-2022, all
rights reserved
Last
updated 27 December
2022
|
